In vitro bioactivity of silicon‐substituted hydroxyapatites
- 9 July 2003
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 66A (2), 364-375
- https://doi.org/10.1002/jbm.a.10579
Abstract
Silicon‐containing hydroxyapatites were synthesized by the controlled crystallization method. Chemical analysis, N2 adsorption, Hg porosimetry, X‐ray diffraction, scanning electron microscopy‐energy‐dispersive X‐ray spectroscopy, and X‐ray photoelectron spectroscopy (XPS) were used to characterize the hydroxyapatite and to monitor the development of a calcium phosphate layer onto the surface of the substrate immersed in a simulated body fluid, that is, in vitro bioactivity tests. The influence of the silicon content and the nature of the starting calcium and phosphorus sources on the in vitro bioactivity of the resulting materials were studied. A sample of silicocarnotite, whose structure is related to that of hydroxyapatite and contains isolated SiO44− anions that isomorphically substitute some PO43− anions, was prepared and used as reference material for XPS studies. An increase of the unit cell parameters with the Si content was observed, which indicated that SiO44− units are present in lattice positions, replacing some PO43− groups. By using XPS it was possible to assess the presence of monomeric SiO44− units in the surface of apatite samples containing 0.8 wt % of silicon, regardless the nature of the starting raw materials, either Ca(NO3)2/(NH4)2HPO4/Si(OCOCH3)4 or Ca(OH)2/H3PO4/Si(OCOCH3)4. However, an increase of the silicon content up to 1.6 wt % leads to the polymerization of the silicate species at the surface. This technique shows silicon enrichment at the surface of the three samples. The in vitro bioactivity assays showed that the formation of an apatite‐like layer onto the surface of silicon‐containing substrates is strongly enhanced as compared with pure silicon‐free hydroxyapatite. The samples containing monomeric silicate species showed higher in vitro bioactivity than that of silicon‐rich sample containing polymeric silicate species. The use of calcium and phosphate salts as precursors lead to materials with higher bioactivity. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 66A: 364–375, 2003Keywords
Funding Information
- Comisión Interministerial de Ciencia y Tecnología (CICYT) (MAT02-00025)
This publication has 26 references indexed in Scilit:
- Controlled Crystallization of Calcium Phosphate ApatitesChemistry of Materials, 2000
- New Bioactive Glass and Changes in Porosity during the Growth of a Carbonate Hydroxyapatite Layer on Glass SurfacesChemistry of Materials, 2000
- Surface and Chemical Study of SiO2·P2O5·CaO·(MgO) Bioactive GlassesChemistry of Materials, 2000
- Chlorapatite (Ca5(PO4)3Cl) Characterization by XPS: An Environmentally Important Secondary MineralSurface Science Spectra, 1999
- Chemical Shifts of Silicon X‐ray Photoelectron Spectra by Polymerization Structures of SilicatesJournal of the American Ceramic Society, 1998
- Effects of silicate ions on the formation and transformation of calcium phosphates in neutral aqueous solutionsJournal of the Chemical Society, Faraday Transactions, 1995
- Structural arrangements at the interface between plasma sprayed calcium phosphates and boneBiomaterials, 1994
- Surface modifications of hydroxyapatite ceramics in aqueous mediaBiomaterials, 1994
- X-ray photoelectron study of some silicon-oxygen compoundsJournal of Electron Spectroscopy and Related Phenomena, 1977
- The crystal structure of Ca5(PO4)2SiO4 (Silico-Carnotite)Tschermaks Mineralogische und Petrographische Mitteilungen, 1971